TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER

The rate of triple-negative breast cancer is 10–24  %, and in recent years it’s one of the most studied subtypes of breast cancer due to its clinical aggressiveness and a small number of molecular targets.The study objective is to evaluate effectiveness of different NAPCT regimens including their de...

Full description

Bibliographic Details
Main Authors: A. D. Zikiryakhodzhaev, M. A. Frolova, E. A. Rasskazova, E. V. Glazkova
Format: Article
Language:Russian
Published: ABV-press 2017-06-01
Series:Opuholi Ženskoj Reproduktivnoj Sistemy
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/538